Trial Profile
A 26-Week Placebo-Controlled Efficacy and Safety Study of Mometasone Furoate/Formoterol Fumarate Combination Formulation Compared With Mometasone Furoate and Formoterol Monotherapy in Subjects With Persistent Asthma Previously Treated With Medium-Dose Inhaled Glucocorticosteroids
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 18 Feb 2022
Price :
$35
*
At a glance
- Drugs Mometasone/formoterol (Primary) ; Formoterol; Mometasone
- Indications Asthma
- Focus Adverse reactions; Registrational; Therapeutic Use
- Sponsors Organon
- 11 Nov 2010 Asthma Control Questionnaire results presented at the 2010 Annual Meeting of the American College of Allergy, Asthma and Immunology.
- 04 Nov 2010 Disease exacerbation results were presented at the 76th Annual Meeting of the American College of Chest Physicians: Chest 2010
- 04 Nov 2010 Asthma Control Questionnaire results were presented at the 76th Annual Meeting of the American College of Chest Physicians: Chest 2010.